Table 2 The difference between survivors and death patients

Mean age (years)

36.0(23.0,53.0)

37.5(23.3,54.3)

-0.3

0.747

Male (%)

120(64.2%)

15(68.2%)

0.1

0.710

Onset time (days)

4.0(2.0,7.0)

4.0(1.8,7.5)

-0.4

0.657

Hospitalized days

19.0(10.0,32.0)

9.0(2.8,18.3)

-3.3

0.001*

Admission to ICU (days)

6.0(3.0,12.0)

7.0(2.5,15.5)

-0.5

0.588

Days of critical condition

10.0(5.0,20.3)

5.0(2.0,15.3)

-2.1

0.038*

Number of rescuing

0.0(0.0,0.0)

1.5(0.8,3.0)

-5.2

<0.001*

Days of advanced care

6.0(3.0,12.0)

7.5(2.8,7.5)

-0.7

0.507

Days of primary care

13.0(7.0,24.0)

1.0(1.0,7.0)

-3.1

0.002*

CSFP

 CSFP ≥ 180mmH₂O

89(47.8%)

20(90.9%)

14.6

<0.001*

 CSFP ≥ 400mmH₂O

25(13.4%)

7(31.8%)

5.1

0.024*

White blood cell abnormality in CSF

124(66.3%)

13(61.9%)

0.2

0.686

Total protein abnormality in CSF

123(65.8%)

14(63.6%)

0.0

0.842

Abnormal imaging

63(34.8%)

14(70.0%)

9.4

0.002*

Abnormal electroencephalogram

52(29.2%)

13(65.0%)

10.4

0.001*

Complication

96(51.3%)

22(100.0%)

19.0

< 0.001*

Causative agent

 Viral

135(72.2%)

12(54.5%)

5.4

0.145

 Bacterial

31(16.6%)

5(22.7%)

 Fungal

7(3.7%)

3(13.6%)

 Tubercular

14(7.5%)

2(9.1%)